R F INDUSTRIES LTD
For the period ended Oct 31, 2024. Filed Jan 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Jan 21, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. FORM 10-K SUMMARY
We may voluntarily include a summary of information required by Form 10-K under this Item 16. We have elected not to include such summary information.
Index
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 596) | F-2 |
|---|---|
| Consolidated Balance Sheets October 31, 2024 and 2023 | F-4 – F-5 |
| Consolidated Statements of Operations Years Ended October 31, 2024 and 2023 | F-6 |
| Consolidated Statements of Stockholders’ Equity Years Ended October 31, 2024 and 2023 | F-7 |
| Consolidated Statements of Cash Flows Years Ended October 31, 2024 and 2023 | F-8 |
| Notes to Consolidated Financial Statements | F-9 – F-23 |
To the Board of Directors and
Stockholders of RF Industries, Ltd.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of RF Industries, Ltd. and Subsidiaries (the “Company”) as of October 31, 2024 and 2023, and the related consolidated statements of operations, stockholders’ equity and cash flows for each of the two years in the period ended October 31, 2024, and the related consolidated notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of October 31, 2024 and 2023, and the results of its operations and its cash flows for each of the years in the two-year period ended October 31, 2024, in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) related to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
Evaluation of Goodwill impairment for the Microlab reporting unit (Note 1 to the Consolidated Financial Statements)
As disclosed in the consolidated financial statements, the Company has goodwill of $8.1 million as of October 31, 2024, and approximately 69.5% of goodwill resides in the Microlab reporting unit. At October 31, 2024, the Company performed a quantitative goodwill impairment assessment on its Microlab reporting unit by comparing the fair value of the reporting unit to its carrying amount, including goodwill. The Company estimated the fair value of this reporting unit using a combination of a discounted cash flows analysis and market-based valuation methodologies.
Significant judgment is exercised by the Company in estimating the fair value of the Microlab reporting unit for purposes of the October 31,2024 goodwill impairment test, specifically:
| ● | The fair value estimate of each reporting unit is sensitive to assumptions such as the discount rate, revenue and expense growth rates, and the forecasted cash flow terminal growth rate. |
| ● | These assumptions are affected by such factors as expected future market or economic conditions. |
Given these factors, auditing management’s quantitative impairment tests for goodwill was challenging, subjective, and complex and required a high degree of auditor judgment.
How Our Audit Addressed the Critical Audit Matter
Our audit procedures related to the fair value of goodwill included the following procedures:
| ● | We gained an understanding of and evaluated the design and implementation of the Company’s internal controls that address the risk of material misstatement related to goodwill impairment; |
| ● | We gained an understanding of the process to estimate future cashflows, including methods, data, and significant assumptions used, in developing the discounted cashflow analysis as well as tested the reasonableness of the underlying data used by the Company in its forecasts; |
| ● | We evaluated management’s significant accounting policies related to impairment of goodwill; |
| ● | We evaluated management’s forecasted revenues and cash flows by comparing the forecasts to the underlying business strategies and growth plans; and |
| ● | With the assistance of our firm’s valuation professionals with specialized skills and knowledge in valuation methods and models, we tested the Company’s discounted cash flow models, including certain assumptions including the terminal value and discount rates. |
/s/CohnReznick LLP
We are uncertain as to the year CohnReznick LLP became the Company’s auditor as 1995 is the earliest year of which we have knowledge.
Tysons, Virginia
January 21, 2025
OCTOBER 31, 2024 AND 2023
| October 31, | October 31, | |
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash and cash equivalents | $839 | $4,897 |
| Trade accounts receivable, net of allowance for credit losses of $159 and $244, respectively | 12,119 | 10,277 |
| Inventories | 14,725 | 18,730 |
| Other current assets | 1,430 | 2,136 |
| TOTAL CURRENT ASSETS | 29,113 | 36,040 |
| Property and equipment: | ||
| Equipment and tooling | 4,825 | 4,796 |
| Furniture and office equipment | 6,300 | 5,631 |
| 11,125 | 10,427 | |
| Less accumulated depreciation | 6,312 | 5,503 |
| Total property and equipment, net | 4,813 | 4,924 |
| Operating lease right-of-use assets, net | 15,265 | 15,689 |
| Goodwill | 8,085 | 8,085 |
| Amortizable intangible assets, net | 11,908 | 13,595 |
| Non-amortizable intangible assets | 1,174 | 1,174 |
| Deferred tax assets | - | 2,494 |
| Other assets | 688 | 277 |
| TOTAL ASSETS | $71,046 | $82,278 |
OCTOBER 31, 2024 AND 2023
| October 31, | October 31, | |
|---|---|---|
| 2024 | 2023 | |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts payable | $3,798 | $3,201 |
| Accrued expenses | 4,247 | 4,572 |
| Line of credit | 8,197 | 1,000 |
| Current portion of Term Loan | - | 2,424 |
| Current portion of operating lease liabilities | 1,848 | 1,314 |
| TOTAL CURRENT LIABILITIES | 18,090 | 12,511 |
| Operating lease liabilities | 18,680 | 19,284 |
| Term Loan, net of debt issuance cost | - | 10,721 |
| Deferred tax liabilities | 210 | - |
| TOTAL LIABILITIES | 36,980 | 42,516 |
| COMMITMENTS AND CONTINGENCIES | ||
| STOCKHOLDERS’ EQUITY | ||
| Common stock - authorized 20,000,000 shares of $0.01 par value; 10,544,431 and 10,343,223 shares issued and outstanding at October 31, 2024 and 2023, respectively | 106 | 104 |
| Additional paid-in capital | 26,988 | 26,087 |
| Retained earnings | 6,972 | 13,571 |
| TOTAL STOCKHOLDERS' EQUITY | 34,066 | 39,762 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $71,046 | $82,278 |
| Twelve Months Ended October 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Net sales | $64,857 | $72,168 |
| Cost of sales | 45,986 | 52,631 |
| Gross profit | 18,871 | 19,537 |
| Operating expenses: | ||
| Engineering | 2,782 | 3,151 |
| Selling and general | 18,912 | 20,183 |
| Total operating expenses | 21,694 | 23,334 |
| Operating loss | (2,823) | (3,797) |
| Other expense | (980) | (453) |
| Loss before provision (benefit) for income taxes | (3,803) | (4,250) |
| Provision (Benefit) for income taxes | 2,796 | (1,172) |
| Consolidated net loss | $(6,599) | $(3,078) |
| Loss per share: | ||
| Basic | $(0.63) | $(0.30) |
| Diluted | $(0.63) | $(0.30) |
| Weighted average shares outstanding: | ||
| Basic | 10,481,835 | 10,283,449 |
| Diluted | 10,481,835 | 10,283,449 |
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’** EQUITY**
(In thousands, except share amounts)
| Additional | |||||
|---|---|---|---|---|---|
| Common Stock · Paid-In · Retained | |||||
| Shares | Amount | Capital | Earnings | Total | |
| Balance, November 1, 2022 | 10,193,287 | $102 | $25,118 | $16,649 | $41,869 |
| Exercise of stock options | 45,000 | - | 85 | - | 85 |
| Stock-based compensation expense | - | - | 898 | - | 898 |
| Issuance of restricted stock | 107,424 | 2 | (2) | - | - |
| Tax withholding related to vesting of restricted stock | (2,488) | - | (12) | - | (12) |
| Consolidated net loss | - | - | - | (3,078) | (3,078) |
| Balance, October 31, 2023 | 10,343,223 | 104 | 26,087 | 13,571 | 39,762 |
| Stock-based compensation expense | - | - | 924 | - | 924 |
| Issuance of restricted stock | 206,229 | 2 | (2) | - | - |
| Tax withholding related to vesting of restricted stock | (5,021) | - | (21) | - | (21) |
| Consolidated net loss | - | - | - | (6,599) | (6,599) |
| Balance, October 31, 2024 | 10,544,431 | $106 | $26,988 | $6,972 | $34,066 |
(In thousands)
| Twelve Months Ended October 31, | ||
|---|---|---|
| 2024 | 2023 | |
| OPERATING ACTIVITIES: | ||
| Consolidated net loss | $(6,599) | $(3,078) |
| Adjustments to reconcile consolidated net loss to net cash provided by operating activities: | ||
| Bad debt expense | 5 | 102 |
| Depreciation and amortization | 2,536 | 2,433 |
| Stock-based compensation expense | 924 | 898 |
| Amortization of debt issuance cost | 113 | 9 |
| Tax payments related to shares cancelled for vested restricted stock awards | (21) | (12) |
| Deferred income taxes | 2,703 | (677) |
| Extinguishment of debt issuance cost | 14 | - |
| Changes in operating assets and liabilities: | ||
| Trade accounts receivable | (1,847) | 4,433 |
| Inventories | 4,005 | 2,323 |
| Other current assets | 706 | 3,713 |
| Right-of-use assets | 355 | 1,477 |
| Other long-term assets | (1) | 18 |
| Accounts payable | 597 | (2,451) |
| Accrued expenses | (325) | (4,244) |
| Income taxes payable | - | (759) |
| Net cash provided by operating activities | 3,165 | 4,185 |
| INVESTING ACTIVITIES: | ||
| Capital expenditures | (738) | (2,483) |
| Net cash used in investing activities | (738) | (2,483) |
| FINANCING ACTIVITIES: | ||
| Proceeds from exercise of stock options | - | 87 |
| Debt issuance cost | (520) | - |
| Line of credit payments | (44,256) | (1,000) |
| Line of credit draws | 51,453 | 2,000 |
| Term Loan payments | (13,162) | (2,424) |
| Net cash used in financiing activities | (6,485) | (1,337) |
| Net decrease in cash and cash equivalents | (4,058) | 365 |
| Cash and cash equivalents, beginning of period | 4,897 | 4,532 |
| Cash and cash equivalents, end of period | $839 | $4,897 |
| Supplemental cash flow information – income taxes paid | $64 | $642 |
| Supplemental cash flow information – interest paid | $883 | $529 |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1–** Business activities and summary of significant accounting policies**
Business activities
RF Industries, Ltd., together with its six wholly-owned subsidiaries (collectively, hereinafter the “Company”, ”we”, “us”, or “our”), primarily engages in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. For internal operating and reporting purposes, and for marketing purposes, as of the end of the fiscal year ended October 31, 2024, we classified our operations into the following six divisions/subsidiaries: (i) The RF Connector and Cable Assembly division designs, manufactures and distributes coaxial connectors and cable assemblies that are integrated with coaxial connectors; (ii) Cables Unlimited, Inc., the subsidiary that manufactures custom and standard cable assemblies, complex hybrid fiber optic power solution cables, adapters, and electromechanical wiring harnesses for communication, computer, LAN, automotive and medical equipment; (iii) Rel-Tech Electronics, Inc., the subsidiary that designs and manufacturers cable assemblies and wiring harnesses for blue chip industrial, oilfield, instrumentation and military customers; (iv) C Enterprises, Inc., the subsidiary that designs and manufactures quality connectivity solutions to telecommunications and data communications distributors; (v) Schroff Technologies International, Ltd., the subsidiary that manufactures and markets intelligent thermal control systems used by telecommunications companies across the U.S. and Canada, and shrouds for small cell integration and installation, and (vi) Microlab, the subsidiary that designs and manufactures high-performance RF and Microwave products enabling signal distribution and deployment of in-building DAS (distributed antenna systems), wireless base stations and small cell networks. The Cables Unlimited and C Enterprises divisions are Corning Cables Systems CAH Connections SM Gold Program members that are authorized to manufacture fiber optic cable assemblies that are backed by Corning Cables Systems’ extended warranty.
Use of estimates
The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results may differ from those estimates.
Principles of consolidation
The accompanying consolidated financial statements include the accounts of RF Industries, Ltd., Cables Unlimited, Inc. (“Cables Unlimited”), Rel-Tech Electronics, Inc. (“Rel-Tech”), C Enterprises, Inc. (“C Enterprises”), Schroff Technologies International, Ltd. (“Schrofftech”), and Microlab/FXR LLC (“Microlab”), wholly-owned subsidiaries of RF Industries, Ltd. All intercompany balances and transactions have been eliminated in consolidation.
Cash equivalents
The Company considers all highly-liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
Revenue recognition
On November 1, 2018, we adopted Accounting Standards Update (“ASU”) No. 2014-09,Revenue from Contracts with Customers (Topic 606), (“ASC 606”) applying the modified retrospective method. The core principle of ASC 606 is that revenue should be recorded in an amount that reflects the consideration to which we expect to be entitled in exchange for goods or services promised to customers. Under ASC 606, we follow a five-step model to: (1) identify the contract with our customer; (2) identify our performance obligations in our contract; (3) determine the transaction price for our contract; (4) allocate the transaction price to our performance obligations; and (5) recognize revenue when (or as) each performance obligation is satisfied. In accordance with this accounting principle, we recognize revenue using the output method at a point in time when finished goods have been transferred to the customer and there are no other obligations to customers after the title of the goods have transferred. Title of goods are transferred based on shipping terms for each customer – for shipments with terms of FOB Shipping Point, title is transferred upon shipment; for shipments with terms of FOB Destination, title is transferred upon delivery.
Inventories
Inventories are stated at the lower of cost or net realizable value, with cost determined using the weighted average cost of accounting. Cost includes materials, labor, and manufacturing overhead related to the purchase and production of inventories. We regularly review inventory quantities on hand, future purchase commitments with our suppliers, and the estimated utility of our inventory. If our review indicates a reduction in utility below carrying value due to damage, physical deterioration, obsolescence, changes in price levels, or other causes, we reduce our inventory to a new cost basis through a charge to cost of sales in the period in which it occurs. The determination of market value and the estimated volume of demand used in the lower of cost or market analysis requires significant judgment.
Property and equipment
Equipment, tooling and furniture are recorded at cost and depreciated over their estimated useful lives (generally three tofive years) using the straight-line method. Expenditures for repairs and maintenance are charged to operations in the period incurred.
Goodwill
Goodwill is recorded when the purchase price paid for an acquisition exceeds the estimated fair value of the net identified tangible and intangible assets acquired. Goodwill is not amortized, but is subject to impairment analysis at least once annually, which we perform in October, or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit’s carrying amount is greater than its fair value.
We assess whether a goodwill impairment exists using both qualitative and quantitative assessments at the reporting level. Our qualitative assessment involves determining whether events or circumstances exist that indicate it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. If based on this qualitative assessment we determine it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, we will not perform a quantitative assessment.
Under the quantitative assessment, the goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss should be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.
We test our goodwill, trademarks and other indefinite-lived assets for impairment at least annually or more frequently if events or changes in circumstances indicate these assets may be impaired. These events or circumstances require significant judgment and could include a significant change in the business climate, legal factors, operating performance indicators, competition and sale or disposition of all or a portion of a division. This analysis requires significant judgments, including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for our business, estimation of the useful life over which cash flows will occur, and determination of our weighted average cost of capital.
As of October 31, 2024 and 2023, we performed a quantitative impairment test analysis for the Microlab reporting unit.
No goodwill impairment was recorded in the years ended October 31, 2024 and 2023.
Goodwill by reporting unit and reportable segment as of October 31, 2024 and 2023, is as follows:
| Reporting Unit | Reportable Segment | Amount |
|---|---|---|
| Cables Unlimited | Custom Cabling | $382,685 |
| Rel-Tech | Custom Cabling | 832,556 |
| Schrofftech | Custom Cabling | 1,127,189 |
| RF Connector and Cable Assembly | RF Connector | 125,000 |
| Microlab | RF Connector | 5,617,139 |
| $8,084,569 | ||
Long-lived assets
We assess property, plant and equipment and intangible assets, which are considered definite-lived assets, for impairment. Definite-lived assets are reviewed when there is evidence that events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We measure recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If property and equipment and intangible assets are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair market value.
We amortize our intangible assets with definite useful lives over their estimated useful lives and review these assets for impairment whenever there are impairment indicators.
We test our goodwill, trademarks and other indefinite-lived assets for impairment at least annually or more frequently if events or changes in circumstances indicate these assets may be impaired. These events or circumstances require significant judgment and could include a significant change in the business climate, legal factors, operating performance indicators, competition and sale or disposition of all or a portion of a division. This analysis requires significant judgments, including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for our business, estimation of the useful life over which cash flows will occur, and determination of our weighted average cost of capital.
As of October 31, 2024 and as of April 30, 2024, we performed an impairment test analysis for the Microlab goodwill reporting unit, as of October 31, 2023, we performed an impairment test analysis for the Microlab reporting unit and as of July 31, 2023, we performed an impairment test analysis for the Schrofftech reporting unit. As noted above, we test our goodwill, trademarks, and indefinite-lived intangible assets for impairment at least annually, which we have traditionally done in the fourth quarter, or on an interim basis when events or changes in circumstances suggest these assets may be impaired. Impairment is measured as the excess of the carrying value of the goodwill or indefinite-lived intangible asset over its fair value.
Impairment may result from a number of factors, including performance deterioration, negative cash flows from operations and/or changes in anticipated future cash flows, changes in business plans, adverse economic or market conditions, or other factors beyond our control. The amount of any impairment must be expensed as a charge to operations. Microlab’s operating results were below forecast for the fiscal year ended October 31, 2024 and the three and six-months ended April 30, 2024 triggered an impairment analysis. Microlab’s operating results were below forecast for the fiscal year ended October 31, 2023 and, Schrofftech’s operating results were below forecast for the three and nine-month ended July 31, 2023 triggered impairment analyses.
As of October 31, 2024, Microlab has a carrying value of $19.8 million, which includes $5.6 million in goodwill and $10.3 million in net amortizable intangible assets. The analyses performed included a blend of the income approach (discounted cash flow method) and market approach (guideline public company method) to reach an estimate of Microlab reporting unit fair value of $21.6 which is in excess of the reporting unit's carrying amount.
The analyses performed in blending the income approach and the market approach incorporates several significant judgments and assumptions about projected revenue and expenses growth, future operating margins, discount rates and the selection of guideline public companies. There are inherent uncertainties related to these assumptions and our judgment in applying them to the impairment analysis. Changes in certain events or circumstances could result in changes to our estimated fair values, and may result in future write-downs to the carrying values of these assets. Impairment charges could adversely affect our financial results, financial ratios and could limit our ability to obtain financing in the future.
No impairment was recorded for the years ended October 31, 2024 or 2023.
Fair value measurement
We measure at fair value certain financial assets and liabilities. Fair value is defined as the price that would be received to sell an asset or transfer a liability in an orderly transaction between market participants at the measurement date. GAAP specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. These two types of inputs have created the following fair-value hierarchy:
Level 1— Quoted prices for identical instruments in active markets;
Level 2— Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and
Level 3— Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
As of October 31, 2024 and 2023, the carrying amounts reflected in the accompanying consolidated balance sheets for cash and cash equivalents, accounts receivable, and accounts payable approximated their carrying value due to their short-term nature.
Intangible assets
Intangible assets consist of the following as of October 31, 2024 and 2023 (in thousands):
| 2024 | 2023 | |
|---|---|---|
| Amortizable intangible assets: | ||
| Non-compete agreement (estimated life five years) | $423 | $423 |
| Accumulated amortization | (423) | (378) |
| - | 45 | |
| Customer relationships (estimated lives 7 - 15 years) | 6,058 | 6,058 |
| Accumulated amortization | (3,848) | (3,461) |
| 2,210 | 2,597 | |
| Backlog (estimated life one - two years) | 327 | 327 |
| Accumulated amortization | (327) | (327) |
| - | - | |
| Patents (estimated life 10 - 14 years) | 368 | 368 |
| Accumulated amortization | (208) | (176) |
| 160 | 192 | |
| Tradename (estimated life 15 years) | 1,700 | 1,700 |
| Accumulated amortization | (302) | (189) |
| 1,398 | 1,511 | |
| Proprietary technology (estimated life 10 years) | 11,100 | 11,100 |
| Accumulated amortization | (2,960) | (1,850) |
| 8,140 | 9,250 | |
| Totals | $11,908 | $13,595 |
| Non-amortizable intangible assets: | ||
| Trademarks | $1,174 | $1,174 |
Amortization expense was $1,688,000 and $1,701,000 for the years ended October 31, 2024 and 2023, respectively. The weighted-average amortization period for the amortizable intangible assets is 7.62 years.
There wasno impairment to trademarks for the years ended October 31, 2024 and 2023.
Estimated amortization expense related to finite-lived intangible assets is as follows (in thousands):
| Year ending | |
|---|---|
| October 31, | Amount |
| 2025 | $1,643 |
| 2026 | 1,643 |
| 2027 | 1,643 |
| 2028 | 1,643 |
| 2029 | 1,639 |
| Thereafter | 3,697 |
| Total | $11,908 |
Advertising
We expense the cost of advertising and promotions as incurred. Advertising costs charged to operations were approximately $361,000 and $76,000 in 2024 and 2023, respectively.
Research and development
Research and development costs are expensed as incurred. Our research and development expenses relate to engineering activities, which consist of the design and development of new products for specific customers, as well as the design and engineering of new or redesigned products for the industry in general. During the years ended October 31, 2024 and 2023, we recognized $2,782,000 and $3,151,000 in engineering expenses, respectively.
Income taxes
We account for income taxes under the asset and liability method, based on the income tax laws and rates in the jurisdictions in which operations are conducted and income is earned. This approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Developing the provision (benefit) for income taxes requires significant judgment and expertise in federal, international and state income tax laws, regulations and strategies, including the determination of deferred tax assets and liabilities and, if necessary, any valuation allowances that may be required for deferred tax assets. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Management’s judgments and tax strategies are subject to audit by various taxing authorities.
We have adopted the provisions of ASC 740-10, which clarifies the accounting for uncertain tax positions. ASC 740-10 requires that we recognize the benefit of tax positions taken or expected to be taken in its tax returns in the consolidated financial statements when it is more likely than not that the position will be sustained upon examination by authorities. We recognize interest and penalties related to certain uncertain tax positions as a component of income tax expense and the accrued interest and penalties are included in deferred and income taxes payable in our consolidated balance sheets. See Note 7 to the consolidated financial statements included in this report for more information on the Company’s accounting for uncertain tax positions.
Stock options
For stock option grants to employees, we recognize compensation expense based on the estimated fair value of the options at the date of grant. Stock-based employee compensation expense is recognized on a straight-line basis over the requisite service period. We issue previously unissued common shares upon the exercise of stock options.
For the fiscal years ended October 31, 2024 and 2023, charges related to stock-based compensation amounted to approximately $924,000 and $898,000, respectively, and is classified in selling and general expense.
Earnings per share
Basic earnings per share is calculated by dividing net (loss) income applicable to common stockholders by the weighted average number of common shares outstanding during the period. The calculation of diluted earnings per share is similar to that of basic earnings per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if all potentially dilutive common shares, principally those issuable upon the exercise of stock options, were issued and the treasury stock method had been applied during the period. The greatest number of shares potentially issuable upon the exercise of stock options in any period for the years ended October 31, 2024 and 2023, that were not included in the computation because they were anti-dilutive, totaled 874,816 and 811,135, respectively.
The following table summarizes the computation of basic and diluted earnings per share:
| 2024 | 2023 | |
|---|---|---|
| Numerators: | ||
| Consolidated net loss (A) | $(6,599,000) | $(3,078,000) |
| Denominators: | ||
| Weighted average shares outstanding for basic earnings per share (B) | 10,481,835 | 10,283,449 |
| Add effects of potentially dilutive securities - assumed exercise of stock options | - | - |
| Weighted average shares outstanding for diluted earnings per share (C) | 10,481,835 | 10,283,449 |
| Basic loss per share (A)/(B) | $(0.63) | $(0.30) |
| Diluted loss per share (A)/(C) | $(0.63) | $(0.30) |
Recent accounting standards
Recently issued accounting pronouncements adopted:
In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-13,Financial Instruments—Credit Losses, which requires a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The guidance is effective for fiscal years beginning after December 15, 2019. In November 2019, the FASB issued ASU 2019-10, Financial Instruments—Credit Losses (Topic 326), which pushes back the effective date for public business entities that are smaller reporting companies, as defined by the SEC, to fiscal years beginning after December 15, 2022. The guidance was effective for the Company beginning on November 1, 2023 and the adoption of this standard had no material impact on the Company’s condensed consolidated financial statements or related disclosures.
Recently issued accounting pronouncements not yet adopted:
In November 2023, the FASB issued ASU 2023-07,Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for our fiscal year ending October 31, 2025, and for interim periods within our fiscal year ending October 31, 2026, with early adoption permitted. We are currently evaluating the potential effect that the updated standard will have on our financial statement disclosures.
In December 2023, the FASB issued ASU 2023-09,Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to expand the disclosure requirements for income taxes, specifically related to the effective tax rate reconciliation and income taxes paid. ASU 2023-09 is effective for our fiscal year ending October 31, 2026, with early adoption permitted. We are currently evaluating the potential effect that the updated standard will have on our financial statement disclosures.
Note 2–** Concentrations of credit risk**
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. We maintain our cash and cash equivalents with high-credit quality financial institutions. At October 31, 2024, we had cash and cash equivalent balances in excess of federally insured limits in the amount of approximately $668,000.
Sales from each customer that were 10% or greater of net sales were as follows:
| October 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Wireless provider | * | 10% |
| Distributor A | * | 10% |
- Less than 10%
For the year ended October 31, 2024, a wireless carrier customer and a distributor customer both accounted for less than 10% of total sales, and approximately 15% and 10% of the total net accounts receivable balance, respectively. For the year ended October 31, 2023, a different wireless carrier customer accounted for approximately 10% of total sales and had no accounts receivable. The same distributor customer accounted for less than 10% of sales and approximately 10% of total net accounts receivable, while another distributor customer accounted for approximately 10% of total sales and for 11% of the total net accounts receivable balance. Although the distributors have been on-going major customers of the Company and the wireless carrier is a newer customer to the Company, the written agreements with these customers do not have any minimum purchase obligations and they could stop buying our products at any time and for any reason. A reduction, delay, or cancellation of orders from these customers or the loss of these customers could significantly reduce our future revenues and profits.
Note 3–** Inventories and major vendors**
Inventories, consisting of materials, labor and manufacturing overhead, are stated at the lower of cost or net realizable value. Cost has been determined using the weighted average cost method. Inventories consist of the following (in thousands):
| 2024 | 2023 | |
|---|---|---|
| Raw materials and supplies | $10,886 | $12,957 |
| Work in process | 530 | 439 |
| Finished goods | 3,309 | 5,334 |
| Totals | $14,725 | $18,730 |
No vendors accounted for 10% of inventory purchases during the fiscal year ended October 31, 2024, andone vendor accounted for 15% of inventory purchases for the fiscal year ended October 31, 2023. We have arrangements with our vendors to purchase products based on purchase orders that we periodically issue.
Note 4–** Other current assets**
Other current assets consist of the following (in thousands):
| 2024 | 2023 | |
|---|---|---|
| Prepaid taxes | $262 | $642 |
| Prepaid expense | 699 | 953 |
| Deposits | 329 | 374 |
| Other | 140 | 167 |
| Totals | $1,430 | $2,136 |
Note 5–** Accrued expenses and other long-term liabilities**
Accrued expenses consist of the following (in thousands):
| 2024 | 2023 | |
|---|---|---|
| Wages payable | $2,357 | $2,461 |
| Accrued receipts | 762 | 1,131 |
| Other accrued expenses | 1,128 | 980 |
| Totals | $4,247 | $4,572 |
Accrued receipts represent purchased inventory for which invoices have not been received.
Note 6–** Segment information**
We aggregate operating divisions intotwo reporting segments that have similar economic characteristics primarily in the following areas: (1) the nature of the product and services; (2) the nature of the production process; (3) the type or class of customer for their products and services; (4) the methods used to distribute their products or services; and (5) if applicable, the nature of the regulatory environment. Based upon this evaluation, as of October 31, 2024, we hadtwo reportable segments – RF Connector and Cable Assembly (“RF Connector”) segment and Custom Cabling Manufacturing and Assembly (“Custom Cabling”) segment.
On August 1, 2023, C Enterprises moved and transitioned its physical operations into the RF Connector office in San Diego, CA. Given the synergies in consolidating both the operating divisions into one building for purposes of management and resource allocation, C Enterprises has now been included in the RF Connector segment. Further, since the acquisition of C Enterprises in 2019, the customer base for the division has shifted more towards distribution as opposed to direct to end customer which is more aligned with the RF Connector segment. The segment change of including C Enterprise as part of the RF Connector segment was made retroactive to the beginning of our fiscal year starting November 1, 2022 and reclassified for fiscal 2022 for comparative purposes. Prior to the transition, C Enterprises was included in the Custom Cabling segment.
The RF Connector segment consists of three divisions and the Custom Cabling segment consists of three divisions. While each segment has similar products and services, there was little overlapping of these services to their customer base. The biggest difference in our reporting segments is in the channels of sales: sales or product and services for the RF Connector segment were primarily through the distribution channel, while the Custom Cabling segment sales were through a combination of distribution and direct to the end customer.
Management identifies segments based on strategic business units that are, in turn, based along market lines. These strategic business units offer products and services to different markets in accordance with their customer base and product usage. For segment reporting purposes, the RF Connector, C Enterprises and Microlab divisions constitutes the RF Connector segment, and the Cables Unlimited, Rel-Tech, and Schrofftech divisions constitute the Custom Cabling segment.
As reviewed by our chief operating decision maker, we evaluate the performance of each reporting segment based on income or loss before income taxes. We charge depreciation and amortization directly to each division within the segment. Accounts receivable, inventory, property and equipment, right-of-use assets, goodwill and intangible assets are the only assets identified by segment. Except as discussed above, the accounting policies for segment reporting are the same for the Company as a whole.
All of our operations are conducted in the United States; however, we derive a portion of our revenue from export sales. We attribute sales to geographic areas based on the location of the customers. The following table presents the sales by geographic area for the years ended October 31, 2024 and 2023 (in thousands):
| 2024 | 2023 | |
|---|---|---|
| United States | $58,843 | $65,781 |
| Foreign Countries: | ||
| Canada | 3,825 | 2,183 |
| Italy | 248 | 1,802 |
| China | 531 | 310 |
| United Kingdom | 523 | 393 |
| All Other | 887 | 1,699 |
| 6,014 | 6,387 | |
| Totals | $64,857 | $72,168 |
Net sales, income (loss) before provision (benefit) for income taxes and other related segment information for the years ended October 31, 2024 and 2023 are as follows (in thousands):
| RF Connector · Custom Cabling | ||||||
|---|---|---|---|---|---|---|
| and · Manufacturing and | ||||||
| 2024 · Cable Assembly · Assembly · Corporate · Total | ||||||
| Net sales | $37,871 | $26,986 | $ | - | $64,857 | |
| (Loss) income before provision (benefit) from income taxes | (3,720) | 1,097 | (1,180 | ) (1) | (3,803) | |
| Depreciation and amortization | 2,132 | 404 | - | 2,536 | ||
| Total assets | 47,537 | 20,552 | 2,957 | 71,046 | ||
| Expenditures for Segment Assets | 704 | 34 | - | 738 | ||
| Net sales | $45,941 | $26,227 | $ | - | $72,168 | |
| Loss before benefit from income taxes | (1,463) | (1,479) | (1,307 | ) (1) | (4,250) | |
| Depreciation and amortization | 1,932 | 501 | - | 2,433 | ||
| Total assets | 55,466 | 17,009 | 9,803 | 82,278 | ||
| Expenditures for Segment Assets | 2,396 | 87 | - | 2,483 | ||
| (1) | Corporate charges are primarily interest expense and non-cash and other one-time expense |
Note 7–** Income tax provision (benefit)**
The provision (benefit) for income taxes for the fiscal years ended October 31, 2024 and 2023 consists of the following (in thousands):
| 2024 · 2023 | |||
|---|---|---|---|
| Current: | |||
| Federal | $ | - | $(501) |
| State | 93 | 6 | |
| 93 | (495) | ||
| Deferred: | |||
| Federal | 1,942 | (438) | |
| State | 761 | (239) | |
| 2,703 | (677) | ||
| $2,796 | $(1,172) | ||
Income tax at the federal statutory rate is reconciled to our actual net provision (benefit) for income taxes as follows (in thousands, except percentages):
| 2024 · 2023 | ||||
|---|---|---|---|---|
| % of Pretax · % of Pretax | ||||
| Amount | Loss | Amount | Income | |
| U.S. federal statutory tax rate | $(799) | 21.0% | $(893) | 21.0% |
| State and local taxes, net of federal tax benefit | (170) | 4.5% | (212) | 5.0% |
| Permanent differences | 14 | -0.4% | 15 | -0.4% |
| Stock options | 45 | -1.2% | 88 | -2.1% |
| R&D credits | (102) | 2.7% | (238) | 5.6% |
| Uncertain tax position reserves | 3 | -0.1% | 13 | -0.3% |
| Return-to-provision adjustments | (34) | 0.9% | (69) | 1.6% |
| Change in the valuation allowance on deferred tax assets | 3,839 | -100.9% | 124 | -2.9% |
| Income tax expense | $2,796 | -73.5% | $(1,172) | 27.5% |
The significant components of deferred income taxes were as follows (in thousands):
| 2024 | 2023 | |
|---|---|---|
| Deferred Tax Assets: | ||
| Allowance for obsolete and slow moving inventory | $522 | $434 |
| Allowance for credit losses | 39 | 63 |
| Compensation accruals | 264 | 275 |
| Stock-based compensation awards | 328 | 213 |
| Uniform capitalization | 277 | 208 |
| Lease liability | 5,221 | 5,177 |
| Others | 55 | 94 |
| Capitalized Section 174 Costs | 1,209 | 864 |
| Research and development tax credit | 282 | 128 |
| 163(j) interest carryforward | 347 | 118 |
| Gross deferred tax assets | 8,544 | 7,574 |
| Valuation allowance | (3,962) | (124) |
| Total deferred tax assets | 4,582 | 7,450 |
| Deferred Tax Liabilities: | ||
| Amortization / intangible assets | (172) | (192) |
| ROU assets | (3,880) | (3,942) |
| Depreciation / equipment and furnishings | (740) | (822) |
| Gross deferred tax liabilities | (4,792) | (4,956) |
| Net deferred tax asset/(liabilities) | $(210) | $2,494 |
Deferred income tax assets and liabilities are recorded for differences between the financial statement and tax basis of the assets and liabilities that will result in taxable or deductible amounts in the future based on enacted laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company assesses all positive and negative evidence in determining if, based on the weight of such evidence, a valuation allowance is required to be recorded against the deferred tax assets as of October 31, 2024. The Company has evaluated future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. In making such judgements, significant weight is given to evidence that can be objectively verified. After analyzing all available evidence, including the recent trend of losses, the Company has determined that it is not more likely than not that all of its deferred tax assets will be realized, and therefore, has recorded a partial valuation allowance of $3.8 million against its federal and combined state deferred tax assets as of October 31, 2024. The change in valuation allowance was $3.8 million and $0.1 million for fiscal 2024 and 2023, respectively.
At October 31, 2024, the Company has gross state net operating loss (NOL) carryforwards of $0.6 million. The state NOL carryforwards of $0.6 million will begin to expire in 2029 unless previously utilized. At October 31, 2024, the Company also has IRC 163(j) interest carryforwards of $1.5 million, which will carry forward indefinitely. At October 31, 2024, the Company also has US federal and state research and development credit carryforwards of $0.1 million and $0.3 million, respectively. The federal credit carryforwards will begin to expire in 2044 unless previously utilized. The state credit carryforwards of $0.2 million will begin to expire in 2029 unless previously utilized and the remainder will carry forward indefinitely.
The provision (benefit) for income taxes was $2.8 million or (73.5%) and ($1.2 million) or 27.5% of income before income taxes for fiscal 2024 and 2023, respectively. The fiscal 2024 effective tax rate differed from the statutory federal rate of 21% primarily as a result of the tax benefit from research and development tax credits, the change in valuation allowance for deferred tax assets and state taxes as shown in the effective tax rate reconciliation table above.
The Company recognizes the benefit of tax positions taken or expected to be taken in its tax returns in the consolidated financial statements when it is more likely than not that the position will be sustained upon examination by authorities. Recognized tax positions are measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement.
A reconciliation of the beginning and ending balance to total uncertain tax positions in fiscal years ended October 31, 2024 and 2023 are as follows:
| 2024 | 2023 | |
|---|---|---|
| Balance, at beginning of year | $178 | $121 |
| Increase for tax positions related to the current year | 47 | 78 |
| Increase (decrease) for tax positions related to prior years | (10) | 2 |
| Statute of limitations expirations | (29) | (23) |
| Balance, at end of year | $186 | $178 |
We had gross unrecognized tax benefits of $186,000 and $178,000 attributable to U.S. federal and state research tax credits as of October 31, 2024 and 2023, respectively. During fiscal 2024, the increase in our gross unrecognized tax benefit was primarily related to increased federal and state research tax credits being generated. The uncertain tax benefit of $81,000 is recorded as a reduction to deferred tax assets and the remainder is recorded in income taxes payable in our consolidated balance sheet and if recognized in the future would impact our effective tax rate. We recognize interest and penalties related to uncertain tax positions in income tax expense. We recognized expense of approximately $28,000 and $20,000 during the years ended October 31, 2024 and 2023, respectively. We believe that an adequate provision has been made for any adjustments that may result from tax examinations. However, it is possible that certain changes may occur within the next twelve months, but we do not anticipate that our accrual for uncertain tax positions will change by a material amount over the next twelve-month period.
We are subject to taxation in the United States and state jurisdictions. Our tax years for October 31, 2021 and forward are subject to examination by the United States and October 31, 2020 and forward with state tax authorities.
Note 8–** Stock options**
Incentive and non-qualified stock option plans
On July 22, 2020, the Company’s Board of Directors adopted the 2020 Equity Incentive Plan (the “2020 Plan”). In September 2020, the Company’s stockholders approved the 2020 Plan by vote as required by NASDAQ. An aggregate of 1,250,000 shares of common stock was set aside and reserved for issuance under the 2020 Plan. At its annual meeting held on September 5, 2024, the Company’s stockholders approved an amendment to the 2020 Plan to increase the number of shares of common stock available for issuance under the plan by 1,000,000 shares. As of October 31, 2024,1,299,269 shares of common stock were remaining for future grants of stock options under the 2020 Plan.
Additional disclosures related to stock option plans
On January 11, 2023, we granted a total of 54,092 shares of restricted stock and 108,181 incentive stock options to one manager and three officers, respectively. The shares of restricted stock and incentive stock options vest over four years as follows: (i)one-quarter of the restricted shares and options shall vest on January 10, 2024 and (ii) the remaining restricted shares and options shall vest in 12 equal quarterly installments over the next three years. Also on January 11, 2023, we granted another manager 50,000 incentive stock options. As of October 31, 2023, the 50,000 incentive stock options granted to manager were cancelled and forfeited as the manager was no longer employed. All incentive stock options expire 10 years from the date of grant.
On August 29, 2023, we granted one employee 10,000 incentive stock options. These options vested with respect to 2,500 shares on the date of grant, and the remaining shares vests in equal installments thereafter on each of the next three anniversaries of August 29, 2023. The options expire 10 years from the date of grant.
On January 11, 2024, we granted incentive stock options to Mr. Dawson for the purchase of 116,667 shares, Mr. Yin for the purchase of 41,667 shares, and Mr. Bibisi for the purchase of 41,667 shares. The incentive stock options vest over four years as follows: (i)one-quarter of the options shall vest on January 11, 2025 and (ii) the remaining options shall vest in 12 equal quarterly installments over the next three years. All incentive stock options expire 10 years from the date of grant. No other options were granted to the named executive officers during the year ended October 31, 2024.
On April 16, 2024, we granted a total of 25,000 incentive stock options to three managers. The shares of incentive stock options vest over four years as follows: (i)one-quarter of the options shall vest on April 16, 2025 and (ii) the remaining and options shall vest in 12 equal quarterly installments over the next three years.
No other shares or options were granted to Company employees during fiscal 2024.
The fair value of each option granted in 2024 and 2023 was estimated on the grant date using the Black-Scholes option pricing model with the following assumptions:
| 2024 | 2023 | |
|---|---|---|
| Weighted average volatility | 53.16% | 54.27% |
| Expected dividends | 0.00% | 0.00% |
| Expected term (in years) | 7.0 | 7.0 |
| Risk-free interest rate | 4.00% | 3.78% |
| Weighted average fair value of options granted during the year | $1.76 | $3.15 |
| Weighted average fair value of options vested during the year | $2.88 | $2.80 |
Expected volatilities are based on historical volatility of our stock price and other factors. We used the historical method to calculate the expected life of the 2024 and 2023 option grants. The expected life represents the period of time that options granted are expected to be outstanding. The risk-free rate is based on the U.S. Treasury rate with a maturity date corresponding to the options’ expected life. The dividend yield is based upon the historical dividend yield on the Company’s common stock.
Additional information regarding all of our outstanding stock options at October 31, 2024 and 2023 and changes in outstanding stock options in 2024 and 2023 follows:
| 2024 · 2023 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Shares or · Weighted · Shares or · Weighted | ||||||||||
| Price Per · Average · Price Per · Average | ||||||||||
| Share · Exercise Price · Share · Exercise Price | ||||||||||
| Outstanding at beginning of year | 754,186 | $6.04 | 691,005 | $5.87 | ||||||
| Options granted | 245,001 | $3.01 | 168,181 | $5.36 | ||||||
| Options exercised | - | $ | - | (45,000) | $1.90 | |||||
| Options canceled or expired | (124,371) | $6.42 | (60,000) | $5.33 | ||||||
| Options outstanding at end of year | 874,816 | $5.10 | 754,186 | $6.04 | ||||||
| Options exercisable at end of year | 478,986 | $5.95 | 479,588 | $6.10 | ||||||
| Options vested and expected to vest at end of year | 874,816 | $5.10 | 748,358 | $6.13 | ||||||
| Option price range at end of year | $1.90 | - | $8.69 | $1.90 | - | $8.69 | ||||
| Aggregate intrinsic value of options exercised during year | $ | - | $144,005 | |||||||
Weighted average remaining contractual life of options outstanding as of October 31, 2024:6.42 years
Weighted average remaining contractual life of options exercisable as of October 31, 2024:4.91 years
Weighted average remaining contractual life of options vested and expected to vest as of October 31, 2024:6.42 years
Aggregate intrinsic value of options outstanding at October 31, 2024: $73,000
Aggregate intrinsic value of options exercisable at October 31, 2024: $50,000
Aggregate intrinsic value of options vested and expected to vest at October 31, 2024: $73,000
As of October 31, 2024, $904,000 and $704,000 of expense with respect to nonvested stock options and restricted shares, respectively, has yet to be recognized but is expected to be recognized over a weighted average period of 1.2 and 1.1 years, respectively.
Note 9–** Retirement plan**
We have a 401(k) plan available to our employees. For the years ended October 31, 2024 and 2023, we contributed and recognized as an expense of $533,000 and $567,000, respectively, which amounts represented 3% of eligible employee earnings under the Company’s Safe Harbor Non-elective Employer Contribution Plan.
Note 10–** Term Loan and Line of credit**
In February 2022, we entered into a loan agreement (the “BofA Loan Agreement”) providing for a revolving line of credit (the “BofA Revolving Credit Facility”) in the amount of $3.0 million and a $17.0 million term loan (“BofA Term Loan”, and together with the BofA Revolving Credit Facility, the “BofA Credit Facility”) with Bank of America, N.A. (“BofA”). Amounts outstanding under the BofA Revolving Credit Facility bore interest at a rate of 2.0% plus the Bloomberg Short-Term Bank Yield Index Rate. All amounts outstanding pursuant to the BofA Credit Facility were repaid by us and the BofA Loan Agreement was terminated in connection with us entering into a new loan and security agreement (the “EBC Credit Agreement”) with Eclipse Business Capital, as administrative agent (“EBC”) on March 15, 2024. Borrowings under the BofA Credit Facility were secured by a security interest in certain assets of the Company and were subject to certain loan covenants. The BofA Credit Facility required the maintenance of certain financial covenants, including: (i) consolidated debt to EBITDA ratio not to exceed 3.00 to 1.00 (the “Debt Test”); (ii) consolidated fixed charge coverage ratio of at least 1.25 to 1.00 (the “FCCR Test”); and (iii) consolidated minimum EBITDA of at least $600,000 for the discrete quarter ended January 31, 2022. In addition, the BofA Credit Facility contained customary affirmative and negative covenants.
On September 12, 2023, we entered into Amendment No. 1 and Waiver to the BofA Loan Agreement (“Loan Amendment No. 1”) with BofA, which, among other matters, provided for a one-time waiver of our failure to comply with (i) the Debt Test for the period ended July 31, 2023 and (ii) the FCCR Test for the period ended July 31, 2023. Loan Amendment No. 1 also waived testing for compliance with the Debt Test and FCCR Test for the quarterly periods ending October 31, 2023, January 31, 2024, April 30, 2024 and July 31, 2024. Further, pursuant to Loan Amendment No. 1, we were required to maintain (i) (a) until September 21, 2023, minimum liquidity (week-end cash balance plus availability from the BofA Revolving Credit Facility) of $4.0 million, and (b) from September 22, 2023 and thereafter, liquidity equal to the greater of (1) $4.0 million or (2)80% of the liquidity that had been forecast for this date at the fourth week of the forecast and (ii) minimum EBITDA of ($400,000), $500,000, $1.0 million, and $1.0 million for the quarters ending October 31, 2023, January 31, 2024, April 30, 2024, and July 31, 2024, respectively.
On January 26, 2024, we entered into Amendment No. 2 to the BofA Loan Agreement (“Loan Amendment No. 2”) with BofA, which, among other matters, eliminated the requirement to maintain minimum EBITDA of $500,000 for the quarter ending January 31, 2024. Under Loan Amendment No. 2, the line of credit available to the Company under the BofA Revolving Credit Facility was lowered from $3.0 million to $500,000. Further, Loan Amendment No. 2 required that we maintain from September 22, 2023 and thereafter, liquidity of at least $2.0 million, rather than the greater of $4.0 million or 80% of the forecast liquidity as was required under Loan Amendment No. 1. Under Loan Amendment No. 2, the Company would have been required to pay an additional fee equal to 1% of the collective outstanding principal balances of the BofA Revolving Credit Facility and BofA Term Loan if the BofA Credit Facility was not repaid in full on or before March 1, 2024. This additional fee, if applicable, would have been due on March 2, 2024. Further, Loan Amendment No. 2 required that the Company make an additional principal payment of $1.0 million on the BofA Term Loan on March 1, 2024, in addition to the existing monthly payments due on the BofA Term Loan. In connection with Loan Amendment No. 2, we paid BofA a $500,000 paydown on the BofA Revolving Credit Facility, thereby reducing the outstanding balance from $1.0 million to $500,000. Loan Amendment No. 2 was considered a modification under ASC 470,Debt.
On February 29, 2024, we entered into Amendment No. 3 to the BofALoan Agreement (“Loan Amendment No. 3”) with BofA, which, among other matters, deferred the requirement that the Company make an additional principal payment of $1.0 million on the BofA Term Loan, from March 1, 2024, as was required under Loan Amendment No. 2, to April 1, 2024. Further, Loan Amendment No. 3 reduced the additional fee the Company was required to pay BofA on March 2, 2024 from 1% of the collective outstanding principal balances of the BofA Revolving Credit Facility and BofA Term Loan as of March 1, 2024 as required under Loan Amendment No. 2, to 0.50% of the collective outstanding principal balances of the BofA Revolving Credit Facility and BofA Term Loan as of March 1, 2024. Additionally, Loan Amendment No. 3 required the Company to pay BofA a fee equal to 0.50% of the collective outstanding principal balances of the BofA Revolving Credit Facility and BofA Term Loan as of March 1, 2024, if the BofA Credit Facility was not repaid in full on or before April 2, 2024 (the “April 2024 Fee”). The April 2024 Fee, if applicable, would have been due on April 2, 2024. We were not required to pay the April 2024 Fee based on our repayment of the BofA Credit Facility prior to April 2, 2024. Under Loan Amendment No. 3, the Company was required to maintain liquidity of at least $2.0 million and pay the remaining outstanding balance of $500,000 on the BofA Revolving Credit Facility by March 1, 2024, as required under Loan Amendment No. 2. Loan Amendment No. 3 was considered a modification under ASC 470,Debt.
On March 15, 2024, we entered into the EBC Credit Agreement and used proceeds from the initial drawings under the EBC Credit Facilities (as defined below) to repay in full outstanding obligations under the BofA Loan Agreement and to pay fees, premiums, costs and expenses, including fees payable in connection with the EBC Credit Agreement. The BofA Loan Agreement was terminated upon entry into the EBC Credit Agreement and is no longer in effect.
The EBC Credit Agreement provides for (i) a senior secured revolving loan facility of up to $15.0 million (the “EBC Revolving Loan Facility”) and (ii) a senior secured revolving credit facility of up to $1.0 million (the “EBC Additional Line” and, together with the EBC Revolving Loan Facility, the “EBC Credit Facilities”) (with a $3.0 million swingline loan sublimit). On June 14, 2024, the parties entered into a First Amendment to the EBC Credit Agreement (the “First Amendment”) providing for a modified EBC Additional Line of $1.0 million through July 12, 2024, $666,666.67 from July 13, 2024 through August 11, 2024 and $333,333.34 from August 12, 2024 through September 10, 2024. Availability of borrowings under the EBC Credit Facilities will be based upon a borrowing base formula and periodic borrowing base certifications valuing certain of our accounts receivable and inventories, as reduced by certain reserves, if any.
In the absence of an Event of Default (as defined in the EBC Credit Agreement) or certain other events (including the inability of EBC to determine the secured overnight financing rate “SOFR”), borrowings under (a) the EBC Revolving Loan Facility accrue interest at a rate of the one-month term SOFR reference rate plus an adjustment of 0.11448% (“Adjusted Term SOFR”) plus 5.00%, and (b) the EBC Additional Line accrue interest at a rate of Adjusted Term SOFR plus 6.50%, in each case subject to a floor of 2.00% for Adjusted Term SOFR. We will be required to pay a commitment fee of 0.50% per annum for the unused portion of the EBC Revolving Loan Facility. In addition to the foregoing unused commitment fee, we are required to pay certain other administrative fees pursuant to the terms of the EBC Credit Agreement.
Borrowings under the EBC Credit Agreement are secured by a security interest in certain assets of the Company and are subject to certain loan covenants. The EBC Credit Facilities require the maintenance of certain financial covenants, including (i) Excess Availability (as defined in the EBC Credit Agreement) of at least, as of any date of determination, an amount equal to the greater of (a) $1.0 million and (b)10% of the Adjusted Borrowing Base (as defined in the EBC Credit Agreement), unless as of the last day of the most recent month for which the monthly financial statements and the related compliance certificate have been or are required to have been delivered to EBC, the Fixed Charge Coverage Ratio (as defined in the EBC Credit Agreement) for the twelve consecutive calendar month period then ended is greater than 1.10 to 1.00; and (ii) a capital expenditure limitation limiting the aggregate cost of all Capital Expenditure (as defined in the EBC Credit Agreement) to $2.5 million during any fiscal year. In addition, the EBC Credit Facilities contain customary affirmative and negative covenants.
We filed the EBC Credit Agreement as Exhibit 10.3 to our Quarterly Report on Form 10-Q for the quarter ended January 31, 2024 and the First Amendment as Exhibit 10.1 to our Quarterly Report on Form 10-Q for the quarter ended July 31, 2024.
Debt issuance costs related to the EBC Credit Agreement totaled $412,000 and were included as part of our other long-term assets balance.
As of October 31, 2024, our outstanding borrowings under the EBC Credit Agreement were $8,197,000. In accordance with ASC 470-10-45,Other Presentations Matters - General, we have classified the outstanding borrowings as part of current liabilities.
Note 11–** Related party transactions**
A portion of our operating space is leased from K&K Unlimited, a company controlled by Darren Clark, the former owner and current President of Cables Unlimited. Cables Unlimited monthly rent expense under the lease was $16,000 through May 30, 2024 then the monthly expense increased to $18,000 for the remainder of the year. The monthly payments also include all utilities, janitorial expense, routine maintenance costs, and costs of insurance for Cables Unlimited’s business operations and equipment. During the fiscal years ended October 31, 2024 and 2023, we paid a total of $218,000 and $208,000 under the leases, respectively.
During fiscal 2023, we paid royalties to Elmec Ltd. (“Elmec”), a European-based company that owns the intellectual property that is used in Schrofftech’s products. One third of Elmec is jointly owned by David Therrien and Richard DeFelice, two of the former owners and current President and Vice President, respectively, of Schrofftech. For the year ended October 31, 2023, we paid a total of $24,000 of royalty payments to Elmec. The expenses related to these transactions are included in cost of goods sold. There wereno royalty payments made for the year ended October 31, 2024.
Note 12–** Cash dividend and declared dividends**
We didnot pay or declare any dividends during fiscal year 2024, nor during fiscal year 2023.
Note 13–** Commitments**
We adopted ASU 2016-02 on November 1, 2019, and elected the practical expedient modified retrospective method whereby the lease qualification and classification was carried over from the accounting for leases under ASC 840. The lease contracts for the corporate headquarters, RF Connector division manufacturing facilities, Cables Unlimited, Rel-Tech, and C Enterprises commenced prior to the effective date of November 1, 2019, and were determined to be operating leases. All other new contracts have been assessed for the existence of a lease and for the proper classification into operating leases. The rate implicit in the leases was undeterminable and, therefore, the discount rate used in all lease contracts is our incremental borrowing rate.
We have operating leases for corporate offices, manufacturing facilities, and certain storage units. Our leases have remaining lease terms ofone year tofive years. A portion of our operating leases are leased from K&K Unlimited, a company controlled by Darren Clark, the former owner and current President of Cables Unlimited, to whom we make rent payments of $16,000 to $18,000 per month.
We also have other operating leases for certain equipment. The components of our facilities and equipment operating lease expenses for the years ended October 31, 2024 and 2023 were as follows (in thousands):
| Fiscal Year Ended | Fiscal Year Ended | |
|---|---|---|
| October 31, 2024 | October 31, 2023 | |
| Operating lease cost | $2,956 | $2,872 |
Other information related to leases was as follows (in thousands):
| October 31, 2024 | October 31, 2023 | |
|---|---|---|
| Supplemental Cash Flows Information | ||
| Right-of-use assets obtained in exchange for lease obligations: | ||
| Operating leases | $1,078 | $6,479 |
| Weighted Average Remaining Lease Term | ||
| Operating leases (in months) | 100.92 | 114.26 |
| Weighted Average Discount Rate | ||
| Operating leases | 6.99% | 6.96% |
Future minimum lease payments under non-cancellable leases as of October 31, 2024 were as follows (in thousands):
| Year ended October 31, | Operating Leases |
|---|---|
| 2025 | $3,227 |
| 2026 | 3,228 |
| 2027 | 3,169 |
| 2028 | 2,997 |
| Thereafter | 14,878 |
| Total future minimum lease payments | 27,499 |
| Less imputed interest | (6,971) |
| Total | $20,528 |
| Reported as of October 31, 2024 | Operating Leases |
|---|---|
| Current portion of operating lease liabilities | $1,848 |
| Operating lease liabilities | 18,680 |
| Total | $20,528 |
As of October 31, 2024, operating lease right-of-use asset was $15.3 million and operating lease liability totaled $20.5 million, of which $1.8 million is classified as current. There wereno finance leases as of October 31, 2024 or 2023.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| RF INDUSTRIES, LTD. | ||
| Date: January 21, 2025 | By: | /s/ ROBERT D. DAWSON |
|---|---|---|
| Robert D. Dawson Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Date: January 21, 2025 | By: /s/ ROBERT D. DAWSON |
|---|---|
| Robert D. Dawson, Director and Chief Executive Officer (Principal Executive Officer) |
| Date: January 21, 2025 | By: /s/ PETER YIN |
|---|---|
| Peter Yin, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | |
| Date: January 21, 2025 | By: /s/ MARK K. HOLDSWORTH Mark Holdsworth, Chairman of the Board of Directors |
| Date: January 21, 2025 | By: /s/ SHERYL CEFALI Sheryl Cefali, Director |
| Date: January 21, 2025 | By: /s/ GERALD T. GARLAND Gerald Garland, Director |
| Date: January 21, 2025 | By: /s/ KAY L. TIDWELL Kay L. Tidwell, Director |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.